SAN DIEGO, May 16, 2018 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced that the Company
is a sponsor of the Society of Lateral Access Surgery (SOLAS)
and its annual meeting being held May 17-19, 2018, in
San Diego. NuVasive was
recently recognized by SOLAS for its longstanding commitment and
the first-ever Global Partner in its new partnership program this
year.
NuVasive founded SOLAS in 2006 and proudly continues as a
sponsor of the organization as an independent medical society. The
mission of SOLAS is to advance minimally disruptive lateral access
spine surgery techniques through clinical research, peer-to-peer
education and membership initiatives. This aligns with the NuVasive
focus of developing minimally-invasive, lateral spine
solutions—including Lateral Single-Position Surgery™—that empower
surgeons to create positive clinical outcomes that improve
patients' lives.
During the Annual SOLAS Meeting, NuVasive will host an industry
workshop, Leading. Expanding. Advancing. Lateral Solutions and
Technologies in the Lumbar Spine, on May
18 from 12:30-2:00 p.m. led by
surgeon faculty J. Alex Thomas,
M.D., Brian Kwon, M.D. and
Gregory M. Mundis, M.D. This is a
non-CME, industry-sponsored educational program. For more
information, visit the SOLAS Program.
"We are pleased to participate in the SOLAS partnership program
and have the opportunity to host a workshop among this group of
lateral-focused surgeons," said Matt
Link, executive vice president, strategy, technology and
corporate development for NuVasive. "The research and education
that has come out of SOLAS over the last 12 years has been
invaluable in the clinical advancement of the lateral approach. As
SOLAS continues to build on their strong academic, educational and
scientific foundation, it is great to see other companies recognize
the importance of this organization and join us as partners to help
SOLAS further its mission."
The NuVasive exhibit will focus on a variety of spine solutions,
including Lateral Single-Position Surgery, the SpineTRACK Registry
and The Better Way Back® Program.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, focused on transforming spine surgery and beyond with
minimally disruptive, procedurally-integrated solutions designed to
deliver reproducible and clinically-proven surgical outcomes. The
Company's portfolio includes access instruments, implantable
hardware, biologics, software systems for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative monitoring
service offerings. With over $1
billion in revenues, NuVasive has an approximate 2,400
person workforce in more than 40 countries serving surgeons,
hospitals and patients. For more information, please visit
www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release
that are not a description of historical facts are forward-looking
statements that involve risks, uncertainties, assumptions and other
factors which, if they do not materialize or prove correct, could
cause NuVasive's results to differ materially from historical
results or those expressed or implied by such forward-looking
statements. The potential risks and uncertainties which contribute
to the uncertain nature of these statements include, among others,
risks associated with acceptance of the Company's surgical products
and procedures by spine surgeons, development and acceptance of new
products or product enhancements, clinical and statistical
verification of the benefits achieved via the use of NuVasive's
products (including the iGA® platform), the Company's ability to
effectually manage inventory as it continues to release new
products, its ability to recruit and retain management and key
personnel, and the other risks and uncertainties described in
NuVasive's news releases and periodic filings with the Securities
and Exchange Commission. NuVasive's public filings with the
Securities and Exchange Commission are available at www.sec.gov.
NuVasive assumes no obligation to update any forward-looking
statement to reflect events or circumstances arising after the date
on which it was made.
View original content with
multimedia:http://www.prnewswire.com/news-releases/nuvasive-sponsors-solas-2018-hosts-workshop-on-latest-lateral-innovations-300646826.html
SOURCE NuVasive, Inc.